• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Avidity Biosciences Inc (NQ: RNA )

    45.09 +0.27 (+0.60%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Avidity Biosciences Inc

    < Previous 1 2 3 4 5 6 Next >
    CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
    Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
    Via Investor's Business Daily
    Peering Into Avidity Biosciences's Recent Short Interest
    Avidity Biosciences's (NASDAQ:RNA) short percent of float has fallen 26.62% since its last report. The company recently reported that it has 6.51 million shares sold short, which is 11.33% of all... 
    Via Benzinga
    EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
    Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information.... 
    Via Benzinga
    Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    Expert Ratings for Avidity Biosciences
    Via Benzinga
    Tesla, Amazon, Novavax, Lennar Corp, Avidity Biosciences: Why These 5 Stocks Are Drawing Retail Investors' Attention Today
    Major Wall Street indices closed in the red on Wednesday despite an anticipated 50 basis points hike by the Federal Reserve as Chair Jerome Powell indicated the need for more data before the central... 
    Via Benzinga
    Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps
    U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision. 
    Via Benzinga
    These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
    Business wins are shining the spotlight on these two companies. 
    Via The Motley Fool
    Avidity Biosciences (NASDAQ: RNA) Posts Positive Phase 1/2 MARINA Data on AOC 1001, Announcing the First Successful Delivery of RNA to Muscle
    Avidity Biosciences, Inc. (NASDAQ: RNA) is engaged as a biopharmaceutical company, which is focused on developing a new class of 
    Via Spotlight Growth
    Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
    Via Benzinga
    How A First-Ever In Gene Silencing Catapulted Avidity Biosciences Into The Stratosphere
    The company tested its efforts in myotonic dystrophy 1, a form of muscular dystrophy. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Avidity Biosciences Shares Gain On Encouraging Data From Early-Stage Myotonic Dystrophy Trial
    Via Benzinga
    REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    What's Going On With Avidity Biosciences Stock?
    Avidity Biosciences Inc (NASDAQ: RNA) shares are trading higher Wednesday after the company announced positive data demonstrating the first-ever successful 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    AiViva's Diverse Product Pipeline Could Have The Potential To Transform Unmet Medical Needs
    AiViva BioPharma is a clinical-stage biotech company developing innovative and transformative treatments and products to address unmet medical needs for a wide array of diseases.  
    Via Benzinga
    Short Interest Sector Focus: Healthcare Sector
    As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
    Via Benzinga
    Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    Nasdaq Turns Higher; Crude Oil Rises Over 2%
    U.S. stocks pared some losses toward the end of trading, with the Nasdaq Composite turning higher on Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers 
    Via Benzinga
    Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday
    U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    US Stocks Turn Lower; Dow Dips 175 Points
    U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 175 points on Tuesday. 
    Via Benzinga
    Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
    Gainers 
    Via Benzinga
    US Stocks Open Higher; Dow Surges 300 Points
    U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday. 
    Via Benzinga
    Highly Rated Avidity Biosciences Hammered After Side Effect Sidelines Study
    The stock has a high IBD Digital rating, but plummeted on the news. 
    Via Investor's Business Daily
    FDA Slaps Clinical Hold On Avidity's Early-Stage Myotonic Dystrophy Trial
    The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences Inc's (NASDAQ: RNA) Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).  
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million. 
    Via Benzinga
    Short Interest Sector Focus: Healthcare Sector
    As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
    Via Benzinga
    7 Unknown Biotech Stocks That Could Rocket in 2023
    Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.